- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.09. | PM Society Digital Awards 2024 - winners announced | ||
| 12.09. | Johnson & Johnson's IL-23 inhibitor Tremfya granted FDA approval for ulcerative colitis | ||
| 12.09. | Sanofi/Regeneron's Dupixent approved by MHRA to treat uncontrolled COPD | ||
| 12.09. | Pfizer's Elrexfio accepted by SMC to treat relapsed and refractory multiple myeloma | ||
| 12.09. | Climate of Health: the prescription for survival | ||
| 11.09. | Sanofi/Regeneron announce positive late-stage results for Dupixent in chronic spontaneous urticaria | ||
| 11.09. | Gilead and AI-focused Genesis partner to develop small molecule therapies | ||
| 11.09. | Merck and Daiichi Sankyo's ADC candidate ifinatamab deruxtecan shows promise in SCLC | ||
| 10.09. | Eli Lilly and Genetic Leap partner to develop RNA-targeted therapies in deal worth $409m | ||
| 10.09. | Regeneron's Libtayo shows durable survival benefits in phase 3 lung cancer study | ||
| 10.09. | GSK shares positive phase 3 results for long-acting biologic in severe asthma | ||
| 09.09. | FDA grants full approval to Travere's Filspari for rare kidney disease IgA nephropathy | ||
| 09.09. | Eli Lilly's once-weekly insulin candidate shows promise in late-stage diabetes trials | ||
| 09.09. | J&J presents positive late-stage results for Rybrevant/Lazcluze combination in NSCLC | ||
| 06.09. | Eli Lilly and HAYA Therapeutics enter metabolic condition partnership worth $1bn | ||
| 06.09. | GSK announces positive late-stage results for IL-5 inhibitor Nucala in COPD | ||
| 06.09. | Pfizer/Valneva share promising results for Lyme disease vaccine candidate | ||
| 06.09. | Worldwide Clinical Trials appoints Alessandra Vignola as president of cardiovascular and metabolic | ||
| 05.09. | MSD's Welireg recommended by NICE to treat rare von Hippel-Lindau disease | ||
| 05.09. | MHRA authorises first in new class of treatment for endometriosis symptoms | ||
| 05.09. | Biogen shares promising results for higher dose nusinersen in spinal muscular atrophy | ||
| 04.09. | Novartis' Fabhalta recommended by NICE to treat rare blood disorder PNH | ||
| 04.09. | Moderna's JN.1-adapted COVID-19 vaccine approved by MHRA for adults and children | ||
| 04.09. | Roche shares positive 48-week results for investigational BTK inhibitor in relapsing MS | ||
| 04.09. | PM Society's sixth Careers Event on 26 February 2025 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
